Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 262

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 262
---
 under which 82,500 performance shares were awarded to the Chief Executive Officer. Of the 8,705 beneficiaries, 50% were women. • At its meeting of December 4, 2024, the Board of Directors awarded a share performance plan, cascaded down into two sub- plans: – a plan under which 15 beneficiaries classified as “Senior Executives” were awarded a total of 82,222 performance shares; – a plan under which five beneficiaries not classified as “Senior Executives” were awarded a total of 6,649 performance shares.

| SANOFIFORM 20-F2024 | 157 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

Of those 20 beneficiaries, 40% were women. The entirety of those awards is contingent upon criteria based on business net income (BNI), free cash flow (FCF) and Corporate Social Responsibility (CSR); in the case of employees classified as “Senior Executives”, two additional criteria based on (i) total shareholder return (TSR) and (ii) the R&D allocation rate were added, accounting for respectively 20% and 10% of the total. Vesting is subject to a non-compete clause. The number of shares awarded to the Chief Executive Officer in 2024 represents 0.4% of the total limit approved by our shareholders at the Annual General Meeting of April 30, 2024 (1.5% of our share capital) and 1.85% of the total amount awarded to all beneficiaries in 2024. The 2024 awards represent a dilution of approximately 0.21% of our undiluted share capital as of December 31, 2024. Not all of our employees were awarded performance shares, but a new voluntary profit-sharing agreement was signed in June 2023, which gives all of our employees an interest in Sanofi’s performance (for more details refer to “— Profit-Sharing Schemes, Employee Savings Schemes and Employee Share Ownership” above). Performance Share Plans

| Source | Date ofshareholderauthorization | Date ofaward     | Totalnumberof sharesawarded | tocorporateofficers(a) | to the 10employeesawardedthe mostshares(b) | Start dateof vestingperiod(c) | Vestingdate      | End of lock-up period | Number ofsharesvested as of12/31/2024 | Number ofrightscanceledas of12/